BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ibecbarcelona.eu
X-WR-CALDESC:Events for Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220701T090000
DTEND;TZID=Europe/Madrid:20220701T174500
DTSTAMP:20260501T014442
CREATED:20220623T112616Z
LAST-MODIFIED:20220623T112616Z
UID:96633-1656666000-1656697500@ibecbarcelona.eu
SUMMARY:THERACAT Conference
DESCRIPTION:Bio-orthogonal catalysis for cancer therapy (THERACAT)\n\n\nTHERACAT is a Marie Skłodowska-Curie European Training Network (MSCA-ITN-ETN) aiming to train a new generation of researchers on the innovative topic of bio-orthogonal catalysis for cancer therapy \nThe development of novel cancer therapies is a major challenge for academic research and pharmaceutical industries. Although the recent progress in traditional treatments such as surgery and chemotherapy improved the clinical outcome of cancer patients\, there is a strong need for new and effective approaches as well as for a new generation of young scientists trained to tackle these challenges from a multidisciplinary perspective. THERACAT establishes an international training programme focused on the development of catalysis-based approaches towards the cure of cancer. In this strategy nano- and micro-particles bearing a catalytic unit are delivered to the tumour site and subsequently non-active prodrugs are administered to the patient. The prodrugs are non-toxic and therefore generate limited side effects. Only at the tumour site the catalytic particles convert the prodrugs into active anticancer compounds that generate a local and strong effect\, as single catalytic species can uncage a large number of drugs. This approach presents several advantages on the classical drug delivery paradigm including limited side effects and prolonged efficacy. \nThe final aim of the THERACAT network is to consolidate Europe as the world leader in novel catalysis-based approach for cancer therapy. \n 
URL:https://ibecbarcelona.eu/event/theracat-conference/
LOCATION:Sala Dolors Aleu\, Parc Científic de Barcelona\, Barcelona\, Spain
CATEGORIES:External symposium / conference / congress
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220715T100000
DTEND;TZID=Europe/Madrid:20220715T120000
DTSTAMP:20260501T014442
CREATED:20220503T132602Z
LAST-MODIFIED:20220503T132602Z
UID:91660-1657879200-1657886400@ibecbarcelona.eu
SUMMARY:PhD Discussions: Marc Azagra and Inês Sousa
DESCRIPTION:Novel Nuclear Magnetic Resonance (NMR) applications in the clinical field\nMarc Azagra\, Molecular Imaging for Precision Medicine Group \nWhen nuclear magnetic resonance (NMR) was described more than half a century ago it appeared to be a curiosity of the quantum world. Since then NMR spectroscopy has become an essential tool not only for chemists\, but also for biochemists\, molecular biologists and even clinicians. Today we are going to explain what is Hyperpolarization NMR\, main differences with thermal NMR acquisitions and two of the projects I am involved with: a new NMR application in clinical diagnosis stage for Liver disease and the first experiment ever performed with High-throughput Hyperpolarized Magnetic Resonance Imaging experiment with a multiwell microfluidic chips using Chemical Shift Imaging (CSI) pulse sequence. \n\n\nVersatile gelatine-based biomaterials compatible with neuronal differentiation: Applications in different systems for brain modelling\nInês Sousa Pereira\, Nanobioengineering Group \nTissue engineering has been focused on recreating the tissue environment of many organs\, such as the brain\, for modelling and for therapeutic approaches during the last years. Recently\, 3D brain in vitro models have been explored as they resemble more accurately physiological conditions of this organ. However\, neuronal cultures are challenging due to the high sensitivity of these cells to changes in their surroundings. \nWe present a hydrogel composed of methacrylated gelatine (GeIMA)\, alginate (AlgMA) and hyaluronic acid (HA) for neural progenitor cell culture in this work. Our goal was to assess the compatibility of GelMA and AlgMA composites with neuronal culture as these two materials are common in tissue engineering applications. HA was added to better mimic the stiffness of the brain tissue. Neuroprogenitor mouse cell line C17.2 was embedded in the gelatine-based formulations and cultured as 3D scaffold in a drop shape or inserted in a microfluidic device. They were also used as bioinks for extrusion bioprinting. We performed the physical characterization of both formulations\, viability studies\, immunostainings to assess the differentiation process and calcium imaging to validate the activity of the cells. \nResults show that hydrogels with and without hyaluronic acid have good porosity\, allowing nutrient and oxygen diffusion. They also present low Young Modulus\, especially for hyaluronic acid formulation\, rendering values similar to the brain tissue.\, the viability of the cells as well as the cell differentiation and connectivity were high after 28 days in culture In the assays with the formulations as scaffolds. The activity of the cells was assessed at day 8 and increased by day 15 for both formulations\, showing that cells were differentiating\, and the neuronal network was maturating. In the bioprinting assays\, the formulations presented high cell viability up to 15 days after printing and day 15 immunostaining showed the expression of neuroprogenitor marker nestin and early neuron marker β-III tubulin. On 3D-brain on the chip assays\, the both formulations had high cell viability up until day 15 of culture\, increasing expression of β-III tubulin as well as cell activity. \nIn conclusion\, our formulations allow long-term cell culture\, including high expression of neuronal markers\, cell connectivity and activity and the presence of HA gave the hydrogel physical characteristics closer to brain tissue while permitting a high cell viability and allowing the differentiation of C17.2 cells. These biomaterials are also suitable as bioinks for extrusion in a bioprinter as proven by the good viability of the cells and the compatibility with the differentiation process. The formulations were also tested in a microfluidic system\, maintaining the viability\, differentiation\, and activity capacities of the cells. Overall\, these results make these hydrogels a promising scaffold for brain modelling\, applicable to 3D long-term culture and differentiation of cells\, such as iPSC-derived neurons. \n  \nThis PhD Discussion session will be held at Tower I\, 11th floor Baobab room\, at 10:00am.
URL:https://ibecbarcelona.eu/event/phd-discussions-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220715T100000
DTEND;TZID=Europe/Madrid:20220715T120000
DTSTAMP:20260501T014442
CREATED:20220503T132602Z
LAST-MODIFIED:20220503T132602Z
UID:96603-1657879200-1657886400@ibecbarcelona.eu
SUMMARY:PhD Discussions: Marc Azagra and Inês Sousa
DESCRIPTION:Novel Nuclear Magnetic Resonance (NMR) applications in the clinical field\nMarc Azagra\, Molecular Imaging for Precision Medicine Group \nWhen nuclear magnetic resonance (NMR) was described more than half a century ago it appeared to be a curiosity of the quantum world. Since then NMR spectroscopy has become an essential tool not only for chemists\, but also for biochemists\, molecular biologists and even clinicians. Today we are going to explain what is Hyperpolarization NMR\, main differences with thermal NMR acquisitions and two of the projects I am involved with: a new NMR application in clinical diagnosis stage for Liver disease and the first experiment ever performed with High-throughput Hyperpolarized Magnetic Resonance Imaging experiment with a multiwell microfluidic chips using Chemical Shift Imaging (CSI) pulse sequence. \n\n\nVersatile gelatine-based biomaterials compatible with neuronal differentiation: Applications in different systems for brain modelling\nInês Sousa Pereira\, Nanobioengineering Group \nTissue engineering has been focused on recreating the tissue environment of many organs\, such as the brain\, for modelling and for therapeutic approaches during the last years. Recently\, 3D brain in vitro models have been explored as they resemble more accurately physiological conditions of this organ. However\, neuronal cultures are challenging due to the high sensitivity of these cells to changes in their surroundings. \nWe present a hydrogel composed of methacrylated gelatine (GeIMA)\, alginate (AlgMA) and hyaluronic acid (HA) for neural progenitor cell culture in this work. Our goal was to assess the compatibility of GelMA and AlgMA composites with neuronal culture as these two materials are common in tissue engineering applications. HA was added to better mimic the stiffness of the brain tissue. Neuroprogenitor mouse cell line C17.2 was embedded in the gelatine-based formulations and cultured as 3D scaffold in a drop shape or inserted in a microfluidic device. They were also used as bioinks for extrusion bioprinting. We performed the physical characterization of both formulations\, viability studies\, immunostainings to assess the differentiation process and calcium imaging to validate the activity of the cells. \nResults show that hydrogels with and without hyaluronic acid have good porosity\, allowing nutrient and oxygen diffusion. They also present low Young Modulus\, especially for hyaluronic acid formulation\, rendering values similar to the brain tissue.\, the viability of the cells as well as the cell differentiation and connectivity were high after 28 days in culture In the assays with the formulations as scaffolds. The activity of the cells was assessed at day 8 and increased by day 15 for both formulations\, showing that cells were differentiating\, and the neuronal network was maturating. In the bioprinting assays\, the formulations presented high cell viability up to 15 days after printing and day 15 immunostaining showed the expression of neuroprogenitor marker nestin and early neuron marker β-III tubulin. On 3D-brain on the chip assays\, the both formulations had high cell viability up until day 15 of culture\, increasing expression of β-III tubulin as well as cell activity. \nIn conclusion\, our formulations allow long-term cell culture\, including high expression of neuronal markers\, cell connectivity and activity and the presence of HA gave the hydrogel physical characteristics closer to brain tissue while permitting a high cell viability and allowing the differentiation of C17.2 cells. These biomaterials are also suitable as bioinks for extrusion in a bioprinter as proven by the good viability of the cells and the compatibility with the differentiation process. The formulations were also tested in a microfluidic system\, maintaining the viability\, differentiation\, and activity capacities of the cells. Overall\, these results make these hydrogels a promising scaffold for brain modelling\, applicable to 3D long-term culture and differentiation of cells\, such as iPSC-derived neurons. \n  \nThis PhD Discussion session will be held at Tower I\, 11th floor Baobab room\, at 10:00am.
URL:https://ibecbarcelona.eu/event/phd-discussions/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220722T080000
DTEND;TZID=Europe/Madrid:20220722T170000
DTSTAMP:20260501T014442
CREATED:20220722T093907Z
LAST-MODIFIED:20220722T094126Z
UID:97829-1658476800-1658509200@ibecbarcelona.eu
SUMMARY:2022 BIST Conference on Precision Medicine
DESCRIPTION:Precision Medicine: Putting discoveries to work\n\n\n\n\n\n\n\nThe Barcelona Institute of Science and Technology (BIST) is pleased to announce its 2022 BIST Conference to discuss the latest developments in an area of priority for BIST research\, this year focusing on Precision Medicine.The Conference will take place on November 10\, in the city of Barcelona. It will include keynote talks\, round-tables\, and selected flash-talks and posters on the topic of Precision Medicine. As in the past year\, the Conference will include satellite events.\n\n\n\nCall for abstractsThe main Conference session on November 10 will include selected 5-minute-long flash talks and a poster session on topics related to Precision Medicine. We invite you to submit your abstract though the form by September 10\, 2022.Instructions for abstract submission: \n\n\n\nPrepare your abstract in a word document to submit. The abstract should include: title\, authors with affiliations\, and a summary of maximum 250 words.During the abstract submission\, you will be asked to choose one of the following topics:DevicesGenetics and genomicsHigh-throughput technologiesModeling (e.g.: stem cells\, organoids\, systems biology)Non-invasive monitoring and imagingPrecision therapies (e.g.: CAR-T)Testing and biomarkers\n\n\n\nA public book of abstracts will be prepared for the Conference. \n\n\n\nYou can submit your abstract here. \n\n\n\nThere is no registration fee for this Conference. \n\n\n\nThe abstracts will be evaluated by the Conference Scientific Committee\, composed by Jorge Ferrer from CRG; Núria Montserrat and Irene Marco Rius from IBEC; Turgut Dururan from ICFO; José A. Garrido and Víctor Puntes from ICN2; and Patrick Aloy and Cayetano Gonzalez from IRB Barcelona.The 2022 BIST Conference\, and especially the Satellite Sessions\, are being prepared by the Organizing Committee\, formed by Gloria Lligadas from CRG; Anke Kleff from IBEC; Lydia Sanmartí from ICFO; Mónica H. Pérez-Temprano from ICIQ; Àlex Argemí from ICN2; and Zoila Babot\, Marta Llorens and Gabby Silberman from BIST.
URL:https://ibecbarcelona.eu/event/2022-bist-conference/
CATEGORIES:External symposium / conference / congress
END:VEVENT
END:VCALENDAR